SPX Technologies saw its IBD SmartSelect Composite Rating jump to 96 Monday, up from 94 the day before.
Lean How — And When — To Sell Stocks
The new score tells you the company is now outperforming 96% of all stocks in terms of the most important fundamental and technical stock-picking criteria.
SPX Technologies is now out of buy range after breaking out from a 157.83 buy point in a cup with handle.
The stock earns a 93 EPS Rating, meaning its recent quarterly and longer-term annual earnings growth is outpacing 93% of all stocks.
Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
In Q2, the company reported 16% earnings-per-share growth. Revenue growth climbed 10%, up from 4% in the prior report. That marks one quarter of accelerating revenue growth.
SPX Technologies earns the No. 6 rank among its peers in the Machinery-General Industrial industry group. DXP Enterprises, ESCO Technologies and Standex International are among the top 5 highly-rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
